{
  "Variants Include": [
    {
      "Gene": "UCHL1",
      "variants": [
        {
          "HGVS": "NM_003352.4:c.89G>A (D30K)",
          "cDNA Change": {
            "transcript": "NM_003352.4",
            "ref": "G",
            "alt": "A",
            "position": "89"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "K",
            "position": "30"
          },
          "Description in input context": "D30K (loss of ubiquitin binding)"
        },
        {
          "HGVS": "NM_003352.4:c.268T>C (C90S)",
          "cDNA Change": {
            "transcript": "NM_003352.4",
            "ref": "T",
            "alt": "C",
            "position": "268"
          },
          "Protein Change": {
            "ref": "C",
            "alt": "S",
            "position": "90"
          },
          "Description in input context": "C90S (loss of hydrolase activity)"
        },
        {
          "HGVS": "NM_003352.4:c.277A>T (I93M)",
          "cDNA Change": {
            "transcript": "NM_003352.4",
            "ref": "A",
            "alt": "T",
            "position": "277"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "M",
            "position": "93"
          },
          "Description in input context": "I93M (Parkinson's-associated mutation)"
        },
        {
          "HGVS": "NM_003352.4:c.94_107del (L32S/L32A/L34S/L34A/L39S/L39A)",
          "cDNA Change": {
            "transcript": "NM_003352.4",
            "ref": "GCTGCTTCTGCT",
            "alt": "AGCGCTTCTGCT",
            "position": "94_107"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "S/A",
            "position": "32/34/39"
          },
          "Description in input context": "Leucine substitutions (reduced secretion)"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001048489.2:c.89G>C (A30P)",
          "cDNA Change": {
            "transcript": "NM_001048489.2",
            "ref": "G",
            "alt": "C",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P (Parkinson's-associated mutation)"
        },
        {
          "HGVS": "NM_001048489.2:c.157G>A (A53T)",
          "cDNA Change": {
            "transcript": "NM_001048489.2",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T (Parkinson's-associated mutation)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0002243"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture and secretion analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293T",
        "Description": "Human embryonic kidney 293T cells were used for transfection."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_003352.4:c.89G>A (D30K)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of ubiquitin binding",
          "Result Description": "D30K showed reduced secretion compared to wild-type."
        },
        {
          "Variant": "NM_003352.4:c.268T>C (C90S)",
          "Conclusion": "Normal",
          "Molecular Effect": "Loss of hydrolase activity",
          "Result Description": "C90S secretion levels were comparable to wild-type."
        },
        {
          "Variant": "NM_003352.4:c.277A>T (I93M)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Pathogenic mutation",
          "Result Description": "I93M exhibited reduced secretion."
        },
        {
          "Variant": "NM_003352.4:c.94_107del (L32S/L32A/L34S/L34A/L39S/L39A)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural disruption",
          "Result Description": "Leucine substitutions significantly reduced secretion."
        },
        {
          "Variant": "NM_001048489.2:c.89G>C (A30P)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Toxic gain-of-function",
          "Result Description": "A30P reduced endogenous UCH-L1 secretion."
        },
        {
          "Variant": "NM_001048489.2:c.157G>A (A53T)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Toxic gain-of-function",
          "Result Description": "A53T reduced endogenous UCH-L1 secretion."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Brefeldin A treatment",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293T",
        "Description": "Cells were treated with Brefeldin A to inhibit secretion."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_003352.4:c.89G>A (D30K)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Disrupted secretion pathway",
          "Result Description": "D30K showed increased retention in the ER after Brefeldin A."
        },
        {
          "Variant": "NM_003352.4:c.268T>C (C90S)",
          "Conclusion": "Normal",
          "Molecular Effect": "Unaffected secretion",
          "Result Description": "C90S localized to the Golgi despite Brefeldin A."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}